Search

Your search keyword '"Yonemura, Y."' showing total 805 results
Start Over Author "Yonemura, Y."
805 results on '"Yonemura, Y."'

1. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry

Author

Marti-Cruchaga, Pablo, Zozaya, Gabriel, Sánchez-Justicia, Carlos, Arjona-Sanchez, A., Aziz, O., Passot, G., Salti, G., Serrano, A., Esquivel, J., Van der Speeten, K., Sommariva, A., Kazi, M., Shariff, U., Martínez-Regueira, F., Piso, P., Yonemura, Y., Turaga, K., Sgarbura, O., Avanish Saklani, A., Tonello, M., Rodriguez-Ortiz, L., Vazquez-Borrego, M.C., Romero-Ruiz, A., and Glehen, O.

Published
2023
Full Text
View/download PDF

2. Development of the poloidal Charge eXchange Recombination Spectroscopy system in Heliotron J

Author

Lu, X. X., Kobayashi, S., Harada, T., Tanohira, S., Ida, K., Nishimura, S., Narushima, Y., Yu, D. L., Zang, L., Nagasaki, K., Kado, S., Okada, H., Minami, T., Ohshima, S., Yamamoto, S., Yonemura, Y., Haji, N., Watanabe, S., Okazaki, H., Kanazawa, T., Adulsiriswad, P., Ishizawa, A., Nakamura, Y., Konoshima, S., and Mizuuchi, T.

Subjects
Physics - Plasma Physics, 82D10 (Primary), 76Xxx (Secondary)
Abstract

A Charge eXchange Recombination Spectroscopy (CXRS) system designed to measure the poloidal rotation velocity is developed in Heliotron J. The poloidal CXRS system measures the carbon emission line (C VI, n=8-7, 529.05nm) and the Doppler shift of the emission line provides the information of plasma rotation velocity. A high throughput photographic-lens monochromator (F/2.8) with 0.73nm/mm dispersion is adopted to achieve high rotation velocity and temporal resolution. Since two heating neutral beams from two tangential injectors (NBI) are used as the diagnostic beams, a wide observation range (0.26 < 0.06) at peripheral region (r/a>0.6). The system design and the calibration method are presented. The initial results of poloidal rotation measurement show an electron diamagnetic rotation in an NBI heated plasma, while an ion diamagnetic rotation is observed when ECH is additionally applied. The evaluated radial electric field profile shows a positive Er at plasma core region in the ECH+NBI plasma, and a negative Er in the NBI heated plasma., Comment: With 20 pages, 10 figures

Published
2018

4. Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI)

Author

Abba, J., Abboud, K., Arvieux, C., Carrere, S., Facy, O., Ferron, G., Lorimier, G., Marchal, F., Rat, P., Tuech, J.-J., Villeneuve, Laurent, Ortega-Deballon, P., Lo Dico, R., Faron, M., Yonemura, Y., Glehen, O., Pocard, M., Sardi, A., Hübner, M., Baratti, D., Liberale, G., Kartheuser, A., de Hingh, I., Sugarbaker, P., Ceelen, W., Moran, B., Robella, M., Quenet, F., Sideris, L., Goere, D., Limbert, M., Sammartino, P., and Morris, D.

Published
2021
Full Text
View/download PDF

7. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry

Author

Arjona-Sanchez, A., primary, Aziz, O., additional, Passot, G., additional, Salti, G., additional, Serrano, A., additional, Esquivel, J., additional, Van der Speeten, K., additional, Sommariva, A., additional, Kazi, M., additional, Shariff, U., additional, Martínez-Regueira, F., additional, Piso, P., additional, Yonemura, Y., additional, Turaga, K., additional, Sgarbura, O., additional, Avanish Saklani, A., additional, Tonello, M., additional, Rodriguez-Ortiz, L., additional, Vazquez-Borrego, M.C., additional, Romero-Ruiz, A., additional, Glehen, O., additional, Marti-Cruchaga, Pablo, additional, Zozaya, Gabriel, additional, and Sánchez-Justicia, Carlos, additional

Published
2023
Full Text
View/download PDF

9. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)

Author

Bushati, M., Rovers, K.P., Sommariva, A., Sugarbaker, P.H., Morris, D.L., Yonemura, Y., Quadros, C.A., Somashekhar, S.P., Ceelen, W., Dubé, P., Li, Y., Verwaal, V.J., Glehen, O., Piso, P., Spiliotis, J., Teo, M.C.C., González-Moreno, S., Cashin, P.H., Lehmann, K., Deraco, M., Moran, B., and de Hingh, I.H.J.T.

Published
2018
Full Text
View/download PDF

10. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study

Author

Ahrendt, S.A., Baik, S.H., Bhatt, A., Cachin, P., Ceelen, W., De Hingh, I., De Simone, M., Dubé, P., Edwards, R.P., Franko, J., Gonzalez-Bayon, L., Gushchin, V., Holtzman, M.P., Hsieh, M.-C., Kecmanovic, D., Lee, K.W., Lehmann, K., Levine, E.A., Liu, Y., Mehta, S., Morris, D.L., O'Dwyer, S., Orsenigo, E., Pande, P.K., Park, E.J., Pingpank, J.F., Piso, P., Rajan, F., Rau, B., Sardi, A., Sideris, L., Sommariva, A., Tentes, A.A.K., Teo, M., Yarema, R., Yonemura, Y., Younan, R., Zaveri, S.S., Zeh, H.J., Abba, J., Abboud, K., Alyami, M., Arvieux, C., Bakrin, N., Bereder, J.-M., Bouzard, D., Brigand, C., Carrère, S., Delroeux, D., Dumont, F., Eveno, C., Facy, O., Guyon, F., Ferron, G., Glehen, O., Kianmanesh, R., Lo Dico, R., Lorimier, G., Marchal, F., Mariani, P., Meeus, P., Msika, S., Ortega-Deballon, P., Paquette, B., Passot, G., Peyrat, P., Pirro, N., Pocard, M., Porcheron, J., Rat, P., Sgarbura, O., Thibaudeau, E., Tuech, J.-J., Zinzindohoue, F., Mehta, Sanket, Schwarz, Lilian, Spiliotis, John, Hsieh, Mao-Chih, Akaishi, Eduardo H., Goere, Diane, Sugarbaker, Paul H., Baratti, Dario, Quenet, François, Bartlett, David L., Villeneuve, Laurent, and Kepenekian, Vahan

Published
2018
Full Text
View/download PDF

11. Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination

Author

Yu HH, Yonemura Y, Hsieh MC, Lu CY, Wu SY, and Shan YS

Subjects
Ovarian teratoma, malignant transformation, peritoneal dissemination, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy., Therapeutics. Pharmacology, RM1-950
Abstract

Hsin-Hsien Yu,1,2 Yutaka Yonemura,3,4 Mao-Chih Hsieh,2,5 Chang-Yun Lu,2 Szu-Yuan Wu,6,7 Yan-Shen Shan1,8 1Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 2Division of General Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; 3Peritoneal Dissemination Center, Kishiwada Tokushukai Hospital, Kishiwada, Japan; 4Department of Surgery, Kusatsu General Hospital, Kusatsu, Shiga, Japan; 5Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 6Department of Radiation Oncology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; 7Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 8Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan Objectives: The prognosis of ovarian teratoma with malignant transformation and peritoneal dissemination (PD) is poor. This condition is rare but associated with a high recurrence rate even after aggressive debulking surgery and adjuvant chemotherapy. In the present paper, we describe our experience of using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for this condition. Methods: The data of ten female patients having ovarian teratoma with malignant transformation and PD between June 2007 and June 2017 were collected and reviewed retrospectively. CRS-HIPEC was performed according to the standard protocol. Patient characteristics, pathological reports, tumor markers, perioperative operative parameters, postoperative events, and disease status during the follow-up period were recorded. Results: The primary ovarian neoplasms were pure mature cystic teratoma with malignant transformation (n=6, including 5 of mucinous adenocarcinoma), mixed germ cell tumor with mature cystic teratoma and yolk sac tumor (YST) (n=1), pure immature teratoma (n=1), immature teratoma with growing teratoma syndrome (GTS) (n=1), and immature teratoma mixed YST with GTS (n=1). The mean levels of tumor markers, including carcinoembryonic antigen, cancer antigen 19-9 (CA19-9), and CA125, were markedly elevated. The recurrence rate was 10%. The median and mean disease-free survival (DFS) after CRS-HIPEC were 22.3 and 36.2 months, respectively, and the 5-year DFS rate is 88%. Conclusion: CRS-HIPEC is a safe therapeutic option for reducing the recurrence rate in selected patients with PD originating from ovarian teratoma with malignant transformation. Keywords: ovarian teratoma, malignant transformation, peritoneal dissemination, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy

Published
2019

12. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center

Author

Yu HH, Yonemura Y, Hsieh MC, Mizumoto A, Wakama S, and Lu CY

Subjects
Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, appendiceal goblet cell carcinomas, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Hsin-Hsien Yu,1,2 Yutaka Yonemura,3–5 Mao-Chih Hsieh,1,2 Akiyoshi Mizumoto,4 Satoshi Wakama,3 Chang-Yun Lu1,2 1Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 2Division of General Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; 3Peritoneal Dissemination Center, Kishiwada Tokushukai Hospital, Kishiwada, Osaka, Japan; 4Department of Surgery, Kusatsu General Hospital, Kusatsu, Shiga, Japan; 5Nonprofit Organization to Support Peritoneal Surface Malignancy Treatment, Kyoto, Osaka, Japan Background: Goblet cell carcinomas (GCCs) of the appendix are rare and aggressive malignancies with early peritoneal dissemination. The aim of the present article is to describe our experience in the management of GCCs with peritoneal carcinomatosis (PC) through cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) and to determine the impact of multiple clinical characteristics on the prognosis.Methods: From a prospectively maintained database of patients receiving CRS and HIPEC for peritoneal surface malignancy, the data of 15 patients with GCC and PC were collected. Neoadjuvant laparoscopic HIPEC was performed if indicated. CRS and HIPEC with mitomycin-C or 5-fluorouracil plus oxaliplatin were performed. Adjuvant chemotherapy was also arranged if suitable for the patient’s condition.Results: Nine males and six females with a mean age of 52.4 years were enrolled. The estimated median survival after the diagnosis of GCC with PC and after definitive CRS–HIPEC was 28 and 17 months, respectively. The 1-, 2-, 3-, 4-year survival rates were 86%, 69%, 57%, and 24%, respectively. Log-rank test revealed that the significant independent risk factors for more favorable outcomes were age >50 years, peritoneal cancer index (PCI)

Published
2017

20. Effect of oxaliplatin-based chemotherapy on chemosensitivity in patients with peritoneal metastasis from colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: proof-of-concept study

Author

Prabhu, A, primary, Brandl, A, additional, Wakama, S, additional, Sako, S, additional, Ishibashi, H, additional, Mizumoto, A, additional, Takao, N, additional, Ichinose, M, additional, Motoi, S, additional, Liu, Y, additional, and Yonemura, Y, additional

Published
2021
Full Text
View/download PDF

21. Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI)

Author

Lo Dico, R., primary, Faron, M., additional, Yonemura, Y., additional, Glehen, O., additional, Pocard, M., additional, Sardi, A., additional, Hübner, M., additional, Baratti, D., additional, Liberale, G., additional, Kartheuser, A., additional, de Hingh, I., additional, Sugarbaker, P., additional, Ceelen, W., additional, Moran, B., additional, Robella, M., additional, Quenet, F., additional, Sideris, L., additional, Goere, D., additional, Limbert, M., additional, Sammartino, P., additional, Morris, D., additional, Abba, J., additional, Abboud, K., additional, Arvieux, C., additional, Carrere, S., additional, Facy, O., additional, Ferron, G., additional, Lorimier, G., additional, Marchal, F., additional, Rat, P., additional, Tuech, J.-J., additional, Villeneuve, Laurent, additional, and Ortega-Deballon, P., additional

Published
2021
Full Text
View/download PDF

24. Education in transfusion medicine for medical students and doctors

Author

Panzer, S., Engelbrecht, S., Cole-Sinclair, M. F., Wood, E. M., Wendel, S., Biagini, S., Zhu, Z., Lefrère, J.-J., Andreu, G., Zunino, T., Cabaud, J.-J., Rouger, P., Garraud, O., Janetzko, K., Müller-Steinhardt, M., van der Burg, P., Brand, A., Agarwal, P., Triyono, T., Gharehbaghian, A., Manny, N., Zelig, O., Takeshita, A., Yonemura, Y., Fujihara, H., Nollet, K. E., Ohto, H., Han, K.-S., Nadarajan, V. S., Berlin, G., Sandler, S. G., Strauss, R. G., and Reesink, H. W.

Published
2013
Full Text
View/download PDF

27. Beam Optics Study on FFA-MERIT Ring

Author

Okita, H., primary, Taniguchi, A., additional, Kuriyama, Y., additional, Uesugi, T., additional, Ishi, Y., additional, Mori, Y, additional, Muto, M., additional, Ono, Y., additional, Ikeda, N., additional, Yonemura, Y., additional, Sato, A., additional, Kinsho, M., additional, Miyake, Y., additional, Yoshimoto, M., additional, and Okabe, K., additional

Published
2019
Full Text
View/download PDF

39. High-density experiments with hydrogen ice pellet injection and analysis of pellet penetration depth in Heliotron J

Author

Motojima, G, primary, Okada, H, additional, Okazaki, H, additional, Kobayashi, S, additional, Nagasaki, K, additional, Sakamoto, R, additional, Yamada, H, additional, Kado, S, additional, Ohshima, S, additional, Minami, T, additional, Kenmochi, N, additional, Ohtani, Y, additional, Nozaki, Y, additional, Yonemura, Y, additional, Nakamura, Y, additional, Konoshima, S, additional, Yamamoto, S., additional, Mizuuchi, T, additional, and Watanabe, K Y, additional

Published
2019
Full Text
View/download PDF

40. PS1115 THE RELATIONSHIP BETWEEN THE PRETREATMENT PNH CLONE SIZE AND CLINICAL COURSE IN PATIENTS WITH BONE MARROW FAILURE SYNDROMES: INTERIM ANALYSIS OF JAPANESE MULTICENTER PROSPECTIVE STUDY

Author

Ueda, Y., primary, Hosokawa, K., additional, Ishiyama, K., additional, Takamori, H., additional, Yonemura, Y., additional, Obara, N., additional, Noji, H., additional, Takahashi, H., additional, Shirasugi, Y., additional, Matsuda, T., additional, Ando, K., additional, Shichishima, T., additional, Ikezoe, T., additional, Chiba, S., additional, Ninomiya, H., additional, Kawaguchi, T., additional, Nishimura, J.-I., additional, Kanakura, Y., additional, and Nakao, S., additional

Published
2019
Full Text
View/download PDF

41. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study

Author

Mehta, Sanket, primary, Schwarz, Lilian, additional, Spiliotis, John, additional, Hsieh, Mao-Chih, additional, Akaishi, Eduardo H., additional, Goere, Diane, additional, Sugarbaker, Paul H., additional, Baratti, Dario, additional, Quenet, François, additional, Bartlett, David L., additional, Villeneuve, Laurent, additional, Kepenekian, Vahan, additional, Ahrendt, S.A., additional, Baik, S.H., additional, Bhatt, A., additional, Cachin, P., additional, Ceelen, W., additional, De Hingh, I., additional, De Simone, M., additional, Dubé, P., additional, Edwards, R.P., additional, Franko, J., additional, Gonzalez-Bayon, L., additional, Gushchin, V., additional, Holtzman, M.P., additional, Hsieh, M.-C., additional, Kecmanovic, D., additional, Lee, K.W., additional, Lehmann, K., additional, Levine, E.A., additional, Liu, Y., additional, Mehta, S., additional, Morris, D.L., additional, O'Dwyer, S., additional, Orsenigo, E., additional, Pande, P.K., additional, Park, E.J., additional, Pingpank, J.F., additional, Piso, P., additional, Rajan, F., additional, Rau, B., additional, Sardi, A., additional, Sideris, L., additional, Sommariva, A., additional, Tentes, A.A.K., additional, Teo, M., additional, Yarema, R., additional, Yonemura, Y., additional, Younan, R., additional, Zaveri, S.S., additional, Zeh, H.J., additional, Abba, J., additional, Abboud, K., additional, Alyami, M., additional, Arvieux, C., additional, Bakrin, N., additional, Bereder, J.-M., additional, Bouzard, D., additional, Brigand, C., additional, Carrère, S., additional, Delroeux, D., additional, Dumont, F., additional, Eveno, C., additional, Facy, O., additional, Guyon, F., additional, Ferron, G., additional, Glehen, O., additional, Kianmanesh, R., additional, Lo Dico, R., additional, Lorimier, G., additional, Marchal, F., additional, Mariani, P., additional, Meeus, P., additional, Msika, S., additional, Ortega-Deballon, P., additional, Paquette, B., additional, Passot, G., additional, Peyrat, P., additional, Pirro, N., additional, Pocard, M., additional, Porcheron, J., additional, Rat, P., additional, Sgarbura, O., additional, Thibaudeau, E., additional, Tuech, J.-J., additional, and Zinzindohoue, F., additional

Published
2018
Full Text
View/download PDF

44. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups

Author

Amblard, I., primary, Mercier, F., additional, Bartlett, D.L., additional, Ahrendt, S.A., additional, Lee, K.W., additional, Zeh, H.J., additional, Levine, E.A., additional, Baratti, D., additional, Deraco, M., additional, Piso, P., additional, Morris, D.L., additional, Rau, B., additional, Tentes, A.A.K., additional, Tuech, J.-J., additional, Quenet, F., additional, Akaishi, E., additional, Pocard, M., additional, Yonemura, Y., additional, Lorimier, G., additional, Delroeux, D., additional, Villeneuve, L., additional, Glehen, O., additional, Passot, G., additional, Abba, J., additional, Abboud, K., additional, Alyami, M., additional, Arvieux, C., additional, Bakrin, N., additional, Bereder, J.-M., additional, Bouzard, D., additional, Brigand, C., additional, Carrère, S., additional, Dumont, F., additional, Eveno, C., additional, Facy, O., additional, Guyon, F., additional, Kianmanesh, R., additional, Lo Dico, R., additional, Marchal, F., additional, Mariani, P., additional, Meeus, P., additional, Msika, S., additional, Ortega-Deballon, P., additional, Paquette, B., additional, Peyrat, P., additional, Pirro, N., additional, Porcheron, J., additional, Rat, P., additional, Sgarbura, O., additional, Thibaudeau, E., additional, Zinzindohoue, F., additional, Baik, S.H., additional, Bhatt, A., additional, Cachin, P., additional, Ceelen, W., additional, De Hingh, I., additional, De Simone, M., additional, Dubé, P., additional, Edwards, R.P., additional, Franko, J., additional, Gonzalez-Bayon, L., additional, Gushchin, V., additional, Holtzman, M.P., additional, Hsieh, M.-C., additional, Kecmanovic, D., additional, Lehmann, K., additional, Liu, Y., additional, Mehta, S., additional, O'Dwyer, S., additional, Orsevigo, E., additional, Pande, P.K., additional, Park, E.J., additional, Pingpank, J.F., additional, Rajan, F., additional, Sardi, A., additional, Sideris, L., additional, Sommariva, A., additional, Spiliotis, J., additional, Sugarbaker, P., additional, Teo, M., additional, Yarema, R., additional, Younan, R., additional, and Zaveri, S.S., additional

Published
2018
Full Text
View/download PDF

45. A new bidirectional intraperitoneal and systemic induction chemotherapy (BISIC) for the peritoneal metastasis from gastric cancer in neoadjuvant setting

Author

Yonemura Y, Olivier Glehen, Sugarbaker P, Emel Canbay, M. Hirano, N. Takao, K. Takeshita, Akiyoshi Mizumoto, Endou Y, and Noguchi K

Subjects
Cisplatin, medicine.medical_specialty, Peritoneal metastasis, business.industry, medicine.medical_treatment, Induction chemotherapy, Cancer, Phases of clinical research, medicine.disease, Gastroenterology, Surgery, Docetaxel, Oral administration, Laparotomy, Internal medicine, medicine, business, medicine.drug
Abstract

A phase II study to evaluate the efficacy and safety of a Bidirectional intraperitoneal and systemic induction chemotherapy (BISIC) were performed in patients with Peritoneal metastasis (PM) from gastric cancer in neoadjuvant setting. Sixty-one patients were treated with oral administration of S1 (60 mg/m 2 /day) for 14 consecutive days, followed by 7 days rest, plus intraperitoneal (i.p.) and intravascular (i.v.) administration of docetaxel and cisplatin (30 mg/m2 each) on day 1 and on day 8. The treatment course was repeated every 3 weeks for 3 times. Positive cytological results in 38 patients before BISIC became negative in 27 (71.1%) patients after BISIC. After BISIC, 44 patients received laparotomy and CRS, and complete cytoreduction was achieved in 28 of 44 patients (64%). During BISIC, side effects of grade 3 and 4 were found in 6 (9.9%) patients. After CRS, 7 (15.8%) and 3 (6.8%) patients developed Grade 3 and 4 complications. The overall operative mortality rate was 4.5% (2/44). Histologic effects on primary tumors were found in 87.9% (29/33 tumors). Complete histologic disappearance of PM was observed in 10 (22.7%) of 44 patients. Median survival time (MST) was 15.1 months, with a one and two-year survival of 62.4%, and 44.0%. BISIC therapy is safe and effective in gastric cancer patients with PM.

Published
2014

47. A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent

Author

Yonemura, Y., primary, Canbay, E., additional, Li, Y., additional, Coccolini, F., additional, Glehen, O., additional, Sugarbaker, P.H., additional, Morris, D., additional, Moran, B., additional, Gonzaletz-Moreno, S., additional, Deraco, M., additional, Piso, P., additional, Elias, D., additional, Batlett, D., additional, Ishibashi, H., additional, Mizumoto, A., additional, Verwaal, V., additional, and Mahtem, H., additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results